![Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade - ScienceDirect Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610820305420-fx1.jpg)
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade - ScienceDirect
![Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness - Momoi - 2021 - Cancer Science - Wiley Online Library Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness - Momoi - 2021 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4f8ecf0b-1061-4c29-b12b-7167db517157/cas15007-fig-0006-m.jpg)
Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness - Momoi - 2021 - Cancer Science - Wiley Online Library
![Diagnostics | Free Full-Text | Renal Complications Related to Checkpoint Inhibitors: Diagnostic and Therapeutic Strategies | HTML Diagnostics | Free Full-Text | Renal Complications Related to Checkpoint Inhibitors: Diagnostic and Therapeutic Strategies | HTML](https://www.mdpi.com/diagnostics/diagnostics-11-01187/article_deploy/html/images/diagnostics-11-01187-g001.png)
Diagnostics | Free Full-Text | Renal Complications Related to Checkpoint Inhibitors: Diagnostic and Therapeutic Strategies | HTML
![Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma | British Journal of Cancer Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fbjc.2014.71/MediaObjects/41416_2014_Article_BFbjc201471_Fig1_HTML.jpg)
Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma | British Journal of Cancer
![Immune evasion in renal cell carcinoma: biology, clinical translation, future directions - Kidney International Immune evasion in renal cell carcinoma: biology, clinical translation, future directions - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f0cae561-490c-4bfd-90c1-bd775bee602d/gr1.jpg)
Immune evasion in renal cell carcinoma: biology, clinical translation, future directions - Kidney International
![Cureus | Use of Immune Checkpoint Inhibitors in Elderly Patients With Chronic Kidney Disease and Renal Cell Carcinoma Metastasis of the Parotid Gland: Case Report and Review of the Literature Cureus | Use of Immune Checkpoint Inhibitors in Elderly Patients With Chronic Kidney Disease and Renal Cell Carcinoma Metastasis of the Parotid Gland: Case Report and Review of the Literature](https://assets.cureus.com/uploads/figure/file/440076/lightbox_69c72460238311edb250a7e23e4151cf-03.-HE-2-5x---prolif-tumorala.png)
Cureus | Use of Immune Checkpoint Inhibitors in Elderly Patients With Chronic Kidney Disease and Renal Cell Carcinoma Metastasis of the Parotid Gland: Case Report and Review of the Literature
![PDF] Immunohistochemical markers in renal tumors and findings in non-tumoral renal parenchyma | Semantic Scholar PDF] Immunohistochemical markers in renal tumors and findings in non-tumoral renal parenchyma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a4e05d7535a89c3cb99b3260ff7b3a9b05568fd2/6-Figure2-1.png)
PDF] Immunohistochemical markers in renal tumors and findings in non-tumoral renal parenchyma | Semantic Scholar
PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma | Aging
![Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610821001173-fx1.jpg)
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect
![Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges](https://f6publishing.blob.core.windows.net/0b6abc97-58ec-47b0-b053-5482cb8ee5e4/WJG-27-4104-g001.png)
Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges
![Clear cell clusters in the kidney: a rare finding that should not be misdiagnosed as renal cell carcinoma | SpringerLink Clear cell clusters in the kidney: a rare finding that should not be misdiagnosed as renal cell carcinoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00428-021-03018-4/MediaObjects/428_2021_3018_Fig2_HTML.png)
Clear cell clusters in the kidney: a rare finding that should not be misdiagnosed as renal cell carcinoma | SpringerLink
World Cancer, Oncology and Therapeutics Congress:Tumoral Pyruvate Kinase L/R as a Predictive Marker for the Treatment of Renal C
![Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma - ScienceDirect Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610821005432-fx1.jpg)
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma - ScienceDirect
Interleukin-15 Plays a Central Role in Human Kidney Physiology and Cancer through the γc Signaling Pathway | PLOS ONE
![MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma | Nature Communications MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncomms15770/MediaObjects/41467_2017_Article_BFncomms15770_Fig1_HTML.jpg)
MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma | Nature Communications
![Frontiers | Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice Frontiers | Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice](https://www.frontiersin.org/files/MyHome%20Article%20Library/494426/494426_Thumb_400.jpg)
Frontiers | Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
![Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type - eBioMedicine Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type - eBioMedicine](https://www.thelancet.com/cms/attachment/8d822e4c-bead-411e-9593-eebccce58297/gr1_lrg.jpg)
Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type - eBioMedicine
![Cureus | Eosinophilic Vacuolated Tumor of Kidney: Clinical Perspective of a New Pathologic Emerging Entity Cureus | Eosinophilic Vacuolated Tumor of Kidney: Clinical Perspective of a New Pathologic Emerging Entity](https://assets.cureus.com/uploads/figure/file/369688/7d0e0800c75211ecb409e517ec0ce1ca-Figure-1.png)